Natamycin, also sold as Natacyn, is a type of white powder that fermented by the bacterium Streptomyces natalensis. Natamycin has an ability to inhibit fungal growth but cannot inhibit the growth of bacteria, it is often used in food industry like yogurt, cheese, raw ham, dry sausage as a natural preservative. Natamycin can also be used in medicine to treat diseases caused by fungi.
This report contains market size and forecasts of Natamycin in global, including the following market information:
Global Natamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Natamycin Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Natamycin companies in 2021 (%)
The global Natamycin market was valued at 191.4 million in 2021 and is projected to reach US$ 290.2 million by 2028, at a CAGR of 6.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Glucose-based Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Natamycin include Danisco, DSM, VGP, Handary, AMTECH BIOTECH, Silver-Elephant, Lanzhou Weiri, Langfang Meihua and Zhengzhou New Frey, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Natamycin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Natamycin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Natamycin Market Segment Percentages, by Type, 2021 (%)
Glucose-based
Lactose-based
Sodium chloride-based
Global Natamycin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Natamycin Market Segment Percentages, by Application, 2021 (%)
Food
Medical
Others
Global Natamycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Natamycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Natamycin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Natamycin revenues share in global market, 2021 (%)
Key companies Natamycin sales in global market, 2017-2022 (Estimated), (MT)
Key companies Natamycin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Danisco
DSM
VGP
Handary
AMTECH BIOTECH
Silver-Elephant
Lanzhou Weiri
Langfang Meihua
Zhengzhou New Frey
Chihon
Jiaozuo Joincare
Beijing Oriental Rada
Pucheng Lifecome